现实中，这款被重金宣传的应用在拥有惊人增长数据的同时，也被许多用户质疑。在社交平台上，一些 用户给出的使用反馈包括但不限于"回答模式过于机械""问答结果模棱两可""功能鸡肋"，更具体的还 有"错误解读体检报告""健康饮食规划方案不准确""症状咨询过程中给出无效建议"等。 隐私安全引发担忧 行业痛点下的长期挑战 除了产品本身的功能存在不足，还有一些用户在使用过程中对阿福涉及到的隐私安全问题表示担忧。在 蚂蚁阿福的用户协议中，提到了"健康档案服务作为本服务中的一项相对独立功能服务，除嵌入本服务 应用端，还会嵌入安诊儿APP、安诊儿支付宝小程序等我们授权许可的第三方应用端"，这也让部分用 户担心，自己的个人健康数据被第三方应用获取后会被滥用。 商报讯（记者 吕文鹃）月活突破3000万，单日提问量超1000万，发布一个月后，蚂蚁集团旗下AI健康 应用"蚂蚁阿福"的最新用户数据出炉。作为目前下载量稳居健康管理类应用第一名的APP，阿福铺天盖 地的宣传广告让许多人都对它印象深刻。这款蚂蚁斥巨资，通过品牌升级、头部明星代言、海量广告投 放等方法造势的APP，现在不仅是国内AI健康应用的代表，也是AI赛道下医疗健康这一细分类 ...

Group 1 - The core theme of the event is "Medical Health Full-Scenario Intelligent Systems," showcasing five major industry intelligent systems by Zhongkang Technology [1] - The drugstore intelligent system and commercial intelligent system attracted significant attention with immersive experience zones, highlighting Zhongkang's leading position in the AI healthcare sector [1] Group 2 - Zhongkang Technology officially released a major upgrade plan for the Zhongkang Drugstore Intelligent System, focusing on five core intelligent systems for collaborative evolution [2] - The upgrade aims to transform the drugstore model from a simple medication provider to a "smart health steward," marking the entry of the pharmaceutical retail industry into an "algorithm-driven" era [2] - The full-chain AI decision-making system is constructed based on vast industry data, enhancing operational insights, member management, product improvement, staff empowerment, and disease management [2] Group 3 - Zhongkang Technology introduced a product matrix of commercial AI intelligent systems, including super individual intelligent systems, AI digital marketing growth platforms, and industrial marketing digital foundations [3] - The solutions empower pharmaceutical companies across marketing decision-making, sales execution, and terminal operations, achieving a sevenfold efficiency increase [3] - The complete value closed loop covers data governance, intelligent applications, and business implementation, redefining digital transformation standards in the pharmaceutical industry [3]